Socioeconomic factors increase mortality after lung cancer surgery
the ONA take:
According to a new study published online in the Journal of the American College of Surgeons, patients with limited education and low income have a greater risk of death within 30 days after undergoing surgery for lung cancer than those who are more educated and have more money.
For the study, researchers analyzed data from over 215,000 lung cancer operation admissions. Results showed that living in lower income households and in less-educated communities were independently associated with higher short-term postoperative mortality, in addition to other factors, including male gender, older age, late-stage cancer, multiple co-morbidities, and larger tumor size.
Specifically, those who resided in communities with a median household income of less than $30,000 had a 25% increased risk of dying after surgery within 30 days. Patients from less-educated communities had a 16% increased risk of death within 30 days compared with those from more educated communities.
"In order to get uniform superior outcomes for our patients, we need to identify the patients who are at risk for worse outcomes," said study co-author Felix G. Fernandez, MD, FACS, a lung surgeon and an assistant professor of surgery at Emory University School of Medicine. Atlanta. "This is the first step in describing where those disparities exist."
Patients with limited education and low income have a greater risk of death within 30 days after undergoing surgery for lung cancer.
- Cholesterol-Lowering Drugs May Prevent Breast Cancer Recurrence
- BBD Regimen Efficacious as First-line Therapy for Myeloma
- Idelalisib Increases Progression-Free Survival in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
- Some Early Breast Cancer Patients Should Have Breast Conservation Instead of Mastectomy
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- Decipher Genomic Classifier Prognostic for Distant Prostate Metastasis
- GUCS 2017: Adjuvant Trials in Post-radical Prostatectomy Prostate Cancer Feasible
- Annual Screening of High-Risk Smokers Only More Cost-effective Than Current Methods
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Metronomic Chemotherapy: Improved Tumor Blood Supply Leads to Better Treatment
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|